| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.1 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |
| mRNA | istradefylline | CTRPv2 | pan-cancer | AAC | 0.09 | 0.1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.078 | 0.1 |